• Thumbnail for Janssen COVID-19 vaccine
    The Janssen COVID‑19 vaccine, (Ad26.COV2.S) sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden...
    141 KB (11,331 words) - 06:12, 24 September 2024
  • S. destroyer tender Search for "ad26"  or "ad-26" on Wikipedia. 26 Air Defence Regiment (India) (26.AD) Ad26.COV2.S, COVID-19 vaccine by Janssen Pharmaceutical...
    629 bytes (122 words) - 22:44, 11 July 2021
  • known as Ad26.COV2.S, is a replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding a stabilized variant of the SARS-CoV-2 S protein...
    322 KB (19,558 words) - 03:33, 16 September 2024
  • Thumbnail for Viral vector vaccine
    With the increasing prevalence of adenoviral vaccines, two vaccines, Ad26.COV2.S and ChadOx1-nCoV-19, have been linked to the rare clotting disorder,...
    32 KB (3,318 words) - 13:35, 14 October 2024
  • Thumbnail for South African Health Products Regulatory Authority
    The South African Health Products Regulatory Authority (SAHPRA) is the organisation in charge of regulating the use of all Health Products throughout the...
    7 KB (567 words) - 12:25, 27 September 2023
  • Thumbnail for Convidecia
    similar to other viral vector vaccines like AZD1222, Gam-COVID-Vac, and Ad26.COV2.S. Its single-dose regimen and normal refrigerator storage requirement...
    37 KB (3,397 words) - 07:19, 24 September 2024
  • Study of Ad26.COV2.S in Adults". 4 August 2020. Archived from the original on 16 September 2020. Retrieved 23 August 2020. "A Study of Ad26.COV2.S for the...
    202 KB (23,039 words) - 16:40, 13 November 2024
  • Thumbnail for History of COVID-19 vaccine development
    granted a provisional determination in relation to its COVID‑19 vaccine, Ad26.COV2.S, in November 2020. On 24 January 2021, the TGA granted provisional approval...
    122 KB (11,033 words) - 06:12, 17 November 2024
  • Thumbnail for First presidency of Donald Trump
    companies to develop COVID-19 vaccines, such as AZD1222, mRNA-1273, and Ad26.COV2-S received funding from this program. In June 2020, amid surges in COVID-19...
    526 KB (49,000 words) - 05:30, 17 November 2024
  • Thumbnail for Operation Warp Speed
    Operation Warp Speed (category U.S. federal government response to the COVID-19 pandemic)
    Operation Warp Speed used BARDA as the financial interface between the U.S. federal government and the biomedical industry. The program was initially...
    71 KB (5,872 words) - 05:25, 14 November 2024
  • Thumbnail for World Health Organization response to the COVID-19 pandemic
    the World Health Organization authorized the Janssen COVID-19 vaccine Ad26.COV2.S for emergency use. The World Health Organization encouraged individual...
    119 KB (12,643 words) - 02:05, 17 November 2024
  • mRNA-1273, the DNA vaccine ZyCoV-D as well as the viral vectors AZD1222, Ad26.COV2.S, Ad5-nCoV, and Sputnik V. In addition, genetic vaccines are being investigated...
    8 KB (1,186 words) - 05:09, 11 June 2024
  • Thumbnail for COVID-19 vaccination in South Africa
    28 July 2020. Retrieved 17 April 2020. "Janssen (Johnson & Johnson): Ad26.COV2.S – COVID19 Vaccine Tracker". covid19.trackvaccines.org. Archived from...
    198 KB (13,219 words) - 03:24, 24 October 2024
  • by the government. 29 January – COVID-19 in the UK: A fourth vaccine, Ad26.COV2.S, is shown to be 66% effective against the virus in a one-dose regimen...
    347 KB (33,588 words) - 21:34, 16 November 2024
  • participation of Colombian volunteers in the Phase III trials of the Ad26.COV2.S vaccine, developed by Janssen Pharmaceuticals. The clinical trials were...
    81 KB (3,944 words) - 10:51, 18 April 2024
  • Thumbnail for United Kingdom responses to the COVID-19 pandemic
    College London LNP-nCoVsaRNA, Novavax NVX-CoV2373, Janssen Pharmaceutica Ad26.COV2.S, and Valneva SE VLA2001. Kobie, Nicole (February 15, 2020). "This is...
    102 KB (10,305 words) - 00:25, 13 September 2024
  • Thumbnail for COVID-19 vaccine clinical research
    DailyMed. U.S. National Institutes of Health. Retrieved 14 December 2020. "Janssen COVID-19 Vaccine – ad26.cov2.s injection, suspension". DailyMed. U.S. National...
    95 KB (18,965 words) - 23:35, 15 September 2024
  • Thumbnail for SARS-CoV-2 Beta variant
    trials. In January, Johnson & Johnson, which held trials for its Janssen (Ad26.COV2.S) vaccine in South Africa, reported the level of protection against moderate...
    72 KB (6,070 words) - 20:49, 10 September 2024
  • participation of Colombian volunteers in the Phase III trials of the Ad26.COV2.S vaccine, developed by Janssen Pharmaceuticals. The clinical trials were...
    142 KB (14,919 words) - 00:10, 13 September 2024
  • Thumbnail for Sputnik V COVID-19 vaccine
    Combination With rAd26-S, Recombinant Adenovirus Type 26 Component of Gam-COVID-Vac Vaccine, for the Prevention of COVID-19". ClinicalTrials.gov. U.S. National...
    154 KB (13,894 words) - 23:13, 20 October 2024